Delivery Order SPE2DR25D3501-SPE2DR26FM1VB
- Not listed
- The Defense Logistics Agency awarded a $41,540.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit doses) on May 30, 2025, with completion scheduled for June 23, 2025. This is a non-set-aside competitive award, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $43,777.71 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30 count) on November 3, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is a child order against the company's larger $999.9 billion...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract utilizes firm fixed pricing with an ultimate completion date of December 5, 2025, and is not set-aside, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) on September 8, 2025, with completion targeted for September 29, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) to support federal medical procurement needs. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of November 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $29,185.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a non-set-aside competitive award with an ultimate completion date of January 9, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $29,185.16 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract is expected to be completed by December 2, 2025, and represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14,592.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Vyndamax 61 mg capsules with an ultimate completion date of January 8, 2026. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This competitively awarded, firm fixed-price delivery order has a ceiling value of $13,846.97 and an ultimate completion date of October 14, 2025. The contract represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM1VBDelivery Order
The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of January 27, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal contract portfolio as a critical vendor for military and veteran healthcare systems. The company's federal procurement history demonstrates extensive capability in delivering pharmaceutical products across multiple therapeutic domains through competitively awarded contracts with consistent firm fixed-price terms. This delivery order for Vyndamax, a neurological treatment medication, reflects the company's ongoing role in supporting federal medical supply chain requirements across diverse therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 1/4/26 |